People on the Move
Oxygen Biotherapeutics
Oxygen Biotherapeutics, a North Carolina company specialising in developing drugs for the critical care market, has appointed Gerald Proehl, the former President and CEO of Santarus, to its Board of Directors.
Proehl has an experienced background in the pharmaceutical industry, having founded Santarus, and later led its sale to Salix Pharmaceuticals for $2.6bn (€1.9bn). He has also held staff or board positions at Hoechst Marion Roussel, Auspex and Sophiris.
The US Food and Drug Administration (FDA) recently awarded Fast Track status to Oxygen’s levosimendan, a drug to reduce morbidity and mortality in cardiac surgery patients.